Search for: "Sandoz, Inc. " Results 541 - 560 of 598
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Oct 2014, 5:36 am by Amy Howe
  Two different articles look ahead at next month’s oral argument in the securities case Omnicare, Inc. v. [read post]
15 Apr 2022, 6:11 am by Searcy Law
GlaxoSmithKline recalled its over-the-counter acid reflux medication Zantac in 2020, and Sandoz Inc. recalled its muscle spasm medication due to high nitrosamine levels the same day Pfizer announced its recall of Accuretic and its generic alternatives. [read post]
3 Feb 2011, 8:39 am by Steve Hall
The shipments of thiopental entering the U.S. originated from an Austrian facility owned by Sandoz International GmbH, a German company, according to the complaint. [read post]
15 Apr 2022, 6:11 am by Searcy Law
GlaxoSmithKline recalled its over-the-counter acid reflux medication Zantac in 2020, and Sandoz Inc. recalled its muscle spasm medication due to high nitrosamine levels the same day Pfizer announced its recall of Accuretic and its generic alternatives. [read post]
15 Apr 2022, 6:11 am by Searcy Law
GlaxoSmithKline recalled its over-the-counter acid reflux medication Zantac in 2020, and Sandoz Inc. recalled its muscle spasm medication due to high nitrosamine levels the same day Pfizer announced its recall of Accuretic and its generic alternatives. [read post]
15 Oct 2014, 10:30 am by Lyle Denniston
Sandoz, Inc., over the differing — and maybe competing — roles of trial judges and a specialized federal appeals court that has a major role in shaping the law of inventions. [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey shows most Americans… [read post]
1 Feb 2022, 4:08 pm by Ben Vernia
Civil enforcement actions against the parties responsible for triggering and fueling the opioid epidemic are a critical part of the department’s ongoing efforts to address this crisis.Consistent with this focus, the largest False Claims Act settlements in the past year resulted from significant resolutions with prescription opioid manufacturers:  Indivior Inc. and Indivior plc (Indivior), and Purdue Pharma (Purdue). [read post]
5 Jan 2010, 10:56 am by Erin Miller
Opinion below (Federal Circuit) Petition for certiorari Brief in opposition Brief in opposition for respondent Sandoz, Inc. [read post]
7 Feb 2008, 10:46 am
Medtronic, Inc., 231 F.3d 216, 230 (6th Cir. 2001).Kemp concluded that the purported "violations" before it were not violations at all - but merely reflected Plaintiffs' incorrect reading of FDA requirements. [read post]
23 Apr 2014, 8:50 am by John Elwood
Sandoz, Inc., 13-854 (granted at the March 28 Conference, relisted twice); Jennings v. [read post]
13 Jun 2017, 4:45 am by Edith Roberts
’” Finally, in Amgen Inc. v. [read post]
16 Feb 2015, 1:44 am
  Never too late 29 [week ending Sunday 18 January] -- Martin Luther King’s movie ‘Selma’ and copyright problems | CJEU’s copyright decisions awaited in 2015 | The Modern Law of Patents reviewed | China becoming a ‘protector’ of patent rights | ‘Je suis charlie’ trade mark in France and OHIM| UK IPO logo’s licensing system | High Court for England and Wales in Enterprise Holdings Inc v… [read post]